Skip to main content
Market intelligence
EVMNSector not reported

Evommune, Inc. insider activity

In the last 90 days, 2 corporate insiders purchased $146,260 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$146,260
Corporate buyers
2
Latest transaction
Jul 8, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 8, 2026Kyle CarverChief Financial OfficerOpen Market Purchase1,000$13.26$13,260
Jul 7, 2026Arthur S KirschDirectorOpen Market Purchase10,000$13.30$133,000
Jun 22, 2026Jeegar Pravinkumar PatelChief Scientific OfficerSale1,488$22.50$33,480